D-0566-2022 Class II Terminated
FDA drug recall D-0566-2022 was initiated by ANI Pharmaceuticals, Inc. on Feb 15, 2022 and is designated Class II. Reason for recall: cGMP Deviations The recall status is terminated (terminated Oct 25, 2022). Affected quantity: 173,499 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Feb 23, 2022
- Initiation Date
- Feb 15, 2022
- Termination Date
- Oct 25, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 173,499 bottles
Product description
Alprazolam Tablets, USP 1.0 mg, packaged in a) 100-count bottles (NDC 67253-902-10), b) 500-count bottles (NDC 67253-902-50), and c) 1000-count bottles (NDC 67253-902-11), Rx only, Distributed by: Par Pharmaceutical Chestnut Ridge, NY 10977
Reason for recall
cGMP Deviations
Distribution pattern
Nationwide within the United States
Code information
Lot #: a) 19B081A, Exp. Date 02/2022; 19E088A, 19E089A, Exp. Date 05/2022 b) 19A102B, Exp. Date 02/2022; 19D067B, 19D068B, Exp. Date 04/2022; 19D070C, Exp. Date 05/2022. c) 19F045C, 19F046C, Exp. Date 06/2022; 19B082C, 19B083C, Exp. Date 03/2022; 19D069C, Exp. Date 05/2022.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0566-2022
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026